BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26745629)

  • 1. Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma.
    He Y; Shao F; Pi W; Shi C; Chen Y; Gong D; Wang B; Cao Z; Tang K
    PLoS One; 2016; 11(1):e0146530. PubMed ID: 26745629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
    Xu G; Wei J; Huangfu B; Gao J; Wang X; Xiao L; Xuan R; Chen Z; Song G
    Mol Carcinog; 2020 Nov; 59(11):1302-1316. PubMed ID: 33006223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
    Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
    Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
    Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
    Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
    Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
    Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
    de Carvalho Fraga CA; Farias LC; de Oliveira MV; Domingos PL; Pereira CS; Silva TF; Roy A; Gomez RS; de Paula AM; Guimarães AL
    Pathol Res Pract; 2014 Dec; 210(12):959-64. PubMed ID: 25441661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
    Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M
    Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
    Pal SK; Nguyen CT; Morita KI; Miki Y; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2016 Nov; 45(10):730-739. PubMed ID: 26850833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma.
    Iamaroon A; Pattamapun K; Piboonniyom SO
    J Oral Sci; 2006 Sep; 48(3):105-9. PubMed ID: 17023741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
    Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
    Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
    Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
    Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).
    Sticht C; Freier K; Knöpfle K; Flechtenmacher C; Pungs S; Hofele C; Hahn M; Joos S; Lichter P
    Neoplasia; 2008 May; 10(5):462-70. PubMed ID: 18472963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
    Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
    J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.